Hospital Universitario Infanta Leonor
Hospital Universitario Infanta Leonor
Madrid, Madrid, Spain6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, acute myeloid leukemia, hematologic disorder, hematopoietic and lymphoid system neoplasm, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 3 | 2026-10-07 | NCT07007312 | |
| Response-adaptive to Epcoritamab In First Relapse: Study to Evaluate the Efficacy of Eptoritamab in Patients With Relapse/Refractory Large B Cell Lymphoma | B-cell neoplasm, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2026-09-29 | NCT07126236 | |
| AI-THEROSCOPE: AI Detection of Subclinical Atherosclerosis From Retinal Images | Cardiovascular Risk; Subclinical Atherosclerosis | Active, not recruiting | Not stated | 2026-06-10 | NCT07628088 | |
| A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome | Primary Sjogrens Disease | Active, not recruiting | Phase 3 | 2026-04-16 | NCT06684847 | |
| Spanish Registry of Patients With IgM Monoclonal Gammopathies | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Waldenstrom macroglobulinemia, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Not stated | 2026-02-23 | NCT05093153 | |
| Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients | Embolism and Thrombosis, Hemic and Lymphatic Diseases, Venous Thrombosis, antiphospholipid syndrome, autoimmune disease, cardiovascular disorder, hematologic disorder, immune system disorder, thrombophilia, thrombotic disease, vascular disorder | Recruiting | Not stated | 2026-01-30 | NCT07372170 |